Independent actions on cyclin-dependent kinases and aryl hydrocarbon receptor mediate the antiproliferative effects of indirubins

Marie Knockaert, Marc Blondel, Stéphane Bach, Maryse Leost, Cem Elbi, Gordon L. Hager, Scott R. Nagy, Dalho Han, Michael Denison, Martine Ffrench, Xiaozhou P. Ryan, Prokopios Magiatis, Panos Polychronopoulos, Paul Greengard, Leandros Skaltsounis, Laurent Meijer

Research output: Contribution to journalArticle

88 Scopus citations

Abstract

Indirubin, a bis-indole obtained from various natural sources, is responsible for the reported antileukemia activity of a Chinese Medicinal recipe, Danggui Longhui Wan. However, its molecular mechanism of action is still not well understood. In addition to inhibition of cyclin-dependent kinases and glycogen synthase kinase-3, indirubins have been reported to activate the aryl hydrocarbon receptor (AhR), a cotranscriptional factor. Here, we confirm the interaction of AhR and indirubin using a series of indirubin derivatives and show that their binding modes to AhR and to protein kinases are unrelated. As reported for other AhR ligands, binding of indirubins to AhR leads to its nuclear translocation. Furthermore, the apparent survival of AhR-/- and +/+ cells, as measured by the MTT assay, is equally sensitive to the kinase-inhibiting indirubins. Thus, the cytotoxic effects of indirubins are AhR-independent and more likely to be linked to protein kinase inhibition. In contrast, a dramatic cytostatic effect, as measured by actual cell counts and associated with a sharp G1 phase arrest, is induced by 1-methyl-indirubins, a subfamily of AhR-active but kinase-inactive indirubins. As shown for TCDD (dioxin), this effect appears to be mediated through the AhR-dependent expression of p27KIP1. Altogether these results suggest that AhR activation, rather than kinase inhibition, is responsible for the cytostatic effects of some indirubins. In contrast, kinase inhibition, rather than AhR activation, represents the main mechanism underlying the cytotoxic properties of this class of promising antitumor molecules.

Original languageEnglish (US)
Pages (from-to)4400-4412
Number of pages13
JournalOncogene
Volume23
Issue number25
DOIs
StatePublished - May 27 2004

Keywords

  • Aryl hydrocarbon receptor
  • Cancer
  • Cyclin-dependent kinase
  • Glycogen synthase kinase
  • GSK-3β
  • Indirubin
  • Kinase inhibitor

ASJC Scopus subject areas

  • Molecular Biology
  • Cancer Research
  • Genetics

Fingerprint Dive into the research topics of 'Independent actions on cyclin-dependent kinases and aryl hydrocarbon receptor mediate the antiproliferative effects of indirubins'. Together they form a unique fingerprint.

  • Cite this

    Knockaert, M., Blondel, M., Bach, S., Leost, M., Elbi, C., Hager, G. L., Nagy, S. R., Han, D., Denison, M., Ffrench, M., Ryan, X. P., Magiatis, P., Polychronopoulos, P., Greengard, P., Skaltsounis, L., & Meijer, L. (2004). Independent actions on cyclin-dependent kinases and aryl hydrocarbon receptor mediate the antiproliferative effects of indirubins. Oncogene, 23(25), 4400-4412. https://doi.org/10.1038/sj.onc.1207535